ALLEVYN Complete Care for Bedsores
(PACCT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of this study is to investigate the use of ALLEVYN◊ COMPLETE CARE Sacrum dressing for the prevention of hospital-acquired pressure injuries in adults. The main question it aims to answer is whether or not the dressing will prevent pressure injury prevention between application and Day 7. Participants will apply a dressing to the lower back/tailbone area as part of their regular care up to 14 days and participate in ongoing checkups by the study team.
Who Is on the Research Team?
Amanda Spitzer, MBA, RN
Principal Investigator
Smith & Nephew, Inc.
Are You a Good Fit for This Trial?
This trial is for adults in critical care units who are at risk of developing bedsores (pressure injuries) on their lower back or tailbone. People already having pressure sores, allergies to dressings, or certain skin conditions may not be able to join.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- ALLEVYN◊ COMPLETE CARE Sacrum
Trial Overview
The study tests whether using the ALLEVYN COMPLETE CARE Sacrum dressing on the lower back/tailbone can help prevent new bedsores in high-risk patients over up to 14 days, compared with standard care.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
ALLEVYN◊ COMPLETE CARE Sacrum as preventative measure for hospital-acquired pressure injuries
Find a Clinic Near You
Who Is Running the Clinical Trial?
Smith & Nephew, Inc.
Lead Sponsor
Dr. Maria Berkman
Smith & Nephew, Inc.
Chief Medical Officer since 2023
MD from Harvard Medical School
Dr. Deepak Nath
Smith & Nephew, Inc.
Chief Executive Officer since 2022
PhD in Theoretical Mechanics, University of California, Berkeley
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.